Prostate carcinoma Gleason score Biopsy
Item
history of biopsy documented prostate cancer (any gleason score)
boolean
C0600139 (UMLS CUI [1,1])
C3203027 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
Prostatectomy In the past | Salvage Radiotherapy to prostate | Salvage Radiotherapy to pelvis | Salvage Radiotherapy to prostate Absent | Salvage Radiotherapy to pelvis Absent | External beam radiotherapy | Brachytherapy | External beam radiotherapy Absent | Brachytherapy Absent
Item
past treatment with prostatectomy with or without salvage prostate/pelvic radiation or primary radiation (external beam or brachytherapy)
boolean
C0033573 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
C0085405 (UMLS CUI [2,1])
C0948317 (UMLS CUI [2,2])
C0085405 (UMLS CUI [3,1])
C1536155 (UMLS CUI [3,2])
C0085405 (UMLS CUI [4,1])
C0948317 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C0085405 (UMLS CUI [5,1])
C1536155 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
C0419095 (UMLS CUI [6])
C0006098 (UMLS CUI [7])
C0419095 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0006098 (UMLS CUI [9,1])
C0332197 (UMLS CUI [9,2])
Prostatectomy In the past TNM clinical staging
Item
if past prostatectomy, pathologic stage no greater than t1-3, n1, m0
boolean
C0033573 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
Prostate-Specific Antigen Recurrence | Prostate-Specific Antigen Doubling Time | Prostate specific antigen measurement
Item
psa recurrence with psadt < 18 months. there is no minimum psa for prostatectomy patients. for patients treated with primary radiation therapy psa should be greater than 2.0 ng/ml
boolean
C0138741 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
C0138741 (UMLS CUI [2,1])
C2986483 (UMLS CUI [2,2])
C0201544 (UMLS CUI [3])
Recurrent disease Absent Physical Examination | Recurrent disease Absent Bone scan | Recurrent disease Absent CT of abdomen | Recurrent disease Absent MRI of abdomen | Recurrent disease Absent CT of Pelvis | Recurrent disease Absent MRI of Pelvis | Recurrent disease Absent Chest X-ray
Item
no evidence of recurrent disease on exam, bone scan, ct/mri abdomen/pelvis or cxr
boolean
C0277556 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C0277556 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0203668 (UMLS CUI [2,3])
C0277556 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0412620 (UMLS CUI [3,3])
C0277556 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0412693 (UMLS CUI [4,3])
C0277556 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0412628 (UMLS CUI [5,3])
C0277556 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0203201 (UMLS CUI [6,3])
C0277556 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
C0039985 (UMLS CUI [7,3])
Antiandrogen therapy Previous | Testosterone Recovered | Testosterone measurement
Item
prior adt allowed if < 6 months and testosterone recovered to within 50 units (ng/dl) of normal range
boolean
C0279492 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0039601 (UMLS CUI [2,1])
C0521108 (UMLS CUI [2,2])
C0523912 (UMLS CUI [3])
ECOG performance status
Item
ecog performance status of 0-1
boolean
C1520224 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count of >1,500
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count > 100,000
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
hg > 8g/dl
boolean
C0518015 (UMLS CUI [1])
Absence Hemorrhage Requirement Intervention | Absence Thrombosis Requirement Intervention
Item
no history of bleeding or thromboses within the last 12 months that required medical intervention
boolean
C0332197 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0040053 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])
C0184661 (UMLS CUI [2,4])
Malignant Neoplasms | Exception Prostate carcinoma | Exception Skin carcinoma
Item
history of cancer within 5 years, other than prostate cancer and non-melanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0699893 (UMLS CUI [3,2])
Medical condition Requirement Adrenal Cortex Hormones
Item
medical condition requiring concomitant corticosteroids
boolean
C3843040 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0001617 (UMLS CUI [1,3])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Prior Chemotherapy allowed | Relationship Chemotherapy cycle Quantity
Item
prior chemotherapy allowed if was < 6 cycles and > 6 months prior to study entry
boolean
C1514457 (UMLS CUI [1,1])
C0683607 (UMLS CUI [1,2])
C0439849 (UMLS CUI [2,1])
C1302181 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Prostate cancer recurrent Local | Secondary malignant neoplasm of prostate
Item
documented local recurrence or metastatic prostate cancer
boolean
C0278838 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C0347001 (UMLS CUI [2])
Protocol Compliance Unable
Item
inability to comply with study and/or follow-up procedures
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy of less than 2 years
boolean
C0023671 (UMLS CUI [1])
Study Subject Participation Status | Experimental drug | Exception Bevacizumab
Item
current, recent (within 4 weeks of the first infusion of this study), or planned participation in an experimental drug study other than a genentech-sponsored bevacizumab cancer study
boolean
C2348568 (UMLS CUI [1])
C0304229 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0796392 (UMLS CUI [3,2])